These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Young scientists ditch postdocs for biotech start-ups. Check Hayden E Nature; 2016 Nov; 539(7627):14-15. PubMed ID: 27808219 [No Abstract] [Full Text] [Related]
25. Japanese giants renew interest in industrial biotech. Sipp D Nat Biotechnol; 2005 Mar; 23(3):275-6. PubMed ID: 15765071 [No Abstract] [Full Text] [Related]
26. Costa Rica's biotech project still on track for end of year. Corrales A Nature; 2008 May; 453(7195):586. PubMed ID: 18509417 [No Abstract] [Full Text] [Related]
27. Japanese firms broaden investment focus to early biotech. Louët S; Sipp D Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631 [No Abstract] [Full Text] [Related]
33. Paring down the company: the effect of consolidation in the European biotech sector. Bassett P Nat Biotechnol; 2003 Jul; 21(7):829-30. PubMed ID: 12833105 [No Abstract] [Full Text] [Related]
34. Mind the (biomedical funding) gap. Klausner A Nat Biotechnol; 2005 Oct; 23(10):1217-8. PubMed ID: 16211055 [No Abstract] [Full Text] [Related]
37. The number on biotech indexes. Jacobs T Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059 [No Abstract] [Full Text] [Related]
38. Biotech marks time in Q3. Lawrence S Nat Biotechnol; 2005 Nov; 23(11):1332. PubMed ID: 16273049 [No Abstract] [Full Text] [Related]
39. IPO plans sour on both sides of the pond. Mitchell P Nat Biotechnol; 2004 Aug; 22(8):929-30. PubMed ID: 15286629 [No Abstract] [Full Text] [Related]
40. Tough times set to continue for US biotech start-ups. Lehrman S Nature; 1999 Jan; 397(6716):191. PubMed ID: 9930684 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]